Zentiva Group, A.s. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Zentiva Group, A.s.

Patent Number:
Title:
Combination Therapy Of Substituted Oxazolidinones
Opposition Date:
Mar 19, 2021
Patent Number:
Title:
Capsule Pharmaceutical Dosage Form Comprising A Suspension Formulation Of An Indolinone Derivative
Opposition Date:
Nov 21, 2018
Patent Number:
Title:
Compositions And Methods Of Treating Pulmonary Hypertension
Opposition Date:
Dec 21, 2017

Want to track Zentiva Group, A.s.?

Feel free to send us a message here and we will get back to you